Table 1 Correlations between PD-L1 Tumor Proportion Score with clinical features in 241 cases

From: Programmed death ligand-1 expression in non-small cell lung cancer in a Western Australian population and correlation with clinicopathologic features

 

No. of cases n = 241

PD-L1 < 1% n = 65 (27%)

PD-L1 1–49% n = 100 (41%)

PD-L1 ≥ 50% n = 76 (32%)

p-value

 

N (%)

Age (years)

 < 60

53 (22)

15 (28)

24 (45)

14 (26)

0.89

 

60–69

75 (31)

19 (25)

31 (41)

25 (33)

 
 

70–79

63 (26)

20 (32)

24 (38)

19 (30)

 
 

 ≥ 80

50 (21)

11 (22)

21 (42)

18 (36)

 

Sex

Male

135 (56)

39 (29)

56 (41)

40 (30)

0.68

 

Female

106 (44)

26 (25)

44 (41)

36 (34)

 

Smoking statusa

Non-smoker

32 (14)

10 (31)

14 (44)

8 (25)

0.68

 

Smoker

200 (86)

53 (27)

82 (41)

65 (32)

 

Stageb

I

38 (16)

9 (24)

20 (53)

9 (24)

0.43

 

II

19 (8)

5 (26)

8 (42)

6 (32)

 
 

III

45 (19)

9 (20)

22 (49)

14 (31)

 
 

IV

136 (57)

43 (32)

47 (35)

46 (34)

 
  1. aNine patients had unknown smoking status
  2. bThree patients were unstaged